维普期刊资源整合服务平台（V6.5）

105篇 您的检索式：作者名="Lonardi"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Targeted therapies in metastatic gastric cancer: Current knowledge and future perspectives显示文摘Gastric cancer(GC)represents a leading cause of cancer related morbidity and mortality worldwide accounting for more than 1 million of newly diagnosed cases and thousands of deaths every year.In the last decade,the development of targeted therapies and the optimization of already available chemotherapeutic drugs has expanded the available treatment options for advanced GC and granted better survival expectations to the patients.At the same time,global efforts have been undertaken to investigate in detail the genomic and epigenomic heterogeneity of this disease,resulting in the identification of new specific and sensitive predictive and prognostic biomarkers and in innovative molecular classifications based on gene expression profiling.Nonetheless,several randomized studies aimed at exploring new innovative agents,such as immune checkpoint inhibitors,failed to demonstrate clinically meaningful survival advantages.Therefore,it is essential to further improve the molecular characterization of GC subgroups in order to provide researchers and medical oncologists with new tools for patients’selection and stratification in future clinical development programs and subsequent trials.The aim of the present manuscript is to provide a global overview of the recent molecular classifications from The Cancer Genome Atlas and the Asian Cancer Research Group and to present key promising developments in the field of immunotherapy and targeted therapies in metastatic GC.	Antonio Pellino Erika Riello Floriana Nappo Stefano Brignola Sabina Murgioni Selma Ahcene Djaballah Sara Lonardi Vittorina Zagonel Massimo Rugge Fotios Loupakis Matteo Fassan	2019	World Journal of Gastroenterology2019，25，38：	9
2	Telomere-Specific Reverse Transcriptase (hTERT) and Cell-free RNA in Plasma as Predictors of Pathologic Tumor Response in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy显示文摘	Salvatore Pucciarelli Enrica Rampazzo Marta Briarava Isacco Maretto Marco Agostini Maura Digito Sonia Keppel Maria Friso Sara Lonardi Antonino Paoli Claudia Mescoli Donato Nitti Anita Rossi	2012	Annals of Surgical Oncology2012，，9：	2
3	Tumor - associated macrophages as major source of APRIL in gastric MALT lymphoma显示文摘	MUNARIF LONARDI S CASSATELLA M A	2011	Blood2011，117，24：	1
4	Advanced gastric cancer(GC) and cancer of the gastro-oesophageal junction(GEJ):focus on targeted therapies显示文摘	Cappetta A Lonardi S Pastorelli D	2012	Crit Rev Oncol Hematol2012，81，1：	1
5	Deleted in colon cancer protein expression in colorectal cancer metastases:a major predictor of survival in patients with unresectable metastatic disease receiving palliative fluorouracil-based chemotherapy显示文摘	Aschele C Debernardis D Lonardi S	2004	J Clin Oncol2004，22，18：	1
6	Primary tumor re- sponse to preoperative ehemoradiation with or without oxa- liplatin in locally advanced rectal cancer: pathologic re- sults of the STAR-01 randomized phase m trial 显示文摘	Aschele C Cionini L Lonardi S	2011	J Clin Oncol2011，29，：	1
7	Tumor-associated macrophages as major source of APRIL in gastric MALT lymphoma显示文摘	Munari F Lonardi S Cassatella MA	2011	Blood2011，117，：	1
8	Radiotherapy for non-small cell lung cancer in patients aged 75 and over,safety,effectiveness and possible impact on survival显示文摘	LONARDI F COELI M PAVANATO G	2000	Lung Cancer2000，28，1：	1
9	Congenital coronary artery anomalies angiographic classification revisited显示文摘	Rigatelli Gianluca Docali Giorgio Rossi Paolo Bovolon Daniela Rossi Daniele Bandello Attilio Lonardi Gabriele Rigatelli Giorgio	2003	The International Journal of Cardiac Imaging2003，，5：	1
10	Identification of CXCL13 as a new marker for follicular dendritic cell sarcoma 显示文摘	VERMI W LONARDI S BOSISIO D	2008	J Pathol2008，216，3：	1
11	Identification of CXCL1 3 as a new marker for follicular dendritic cell sarcoma显示文摘	Vermi W Lonardi S Bosisio D	2008	J Pathol2008，216，3：	1
12	Natural glycan microarrays 显示文摘	Lonardi E Balog Decider C I A	2010	Expert Review of Proteomics2010，7，5：	1
13	Identification of CXCL13 as a new marker for follicular dendritic cell sarcoma显示文摘	Vermi W Lonardi S Bosisio D	2008	J Pathol2008，216，3：	1
14	A prospective validation pharmacogenomic study in the adjuvant setting of colorectal cancer patients treated with the 5-fluorouracil/leucovorin/oxaliplatin(FOLFOX4)regimen显示文摘	Cecchin E D’Andrea M Lonardi S	2013	Pharmacogenomics2013，13，5：	1
15	Primary tumor response to preoperative chemoradiation with or without oxaliplatinin locally advanced rectal cancer: pathologic results of the STAR-01 randomizedphase III trial显示文摘	Aschele C Cionini L Lonardi S	2011	J Clin Oncol2011，29，20：	1
16	Advanced gastric cancer(GC) and cancer of the gastro-oesophageal junction (GEJ): focus ontargeted therapies显示文摘	Cappetta A Lonardi S Pastorelli D	2012	Crit Rev Oncol Hematol2012，81，1：	1
17	Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR~01 ran- domized phase II1 trial 显示文摘	Aschele C Cionini L Lonardi S et at	2011	J Clin Oncol2011，29，20：	1
18	Primary tumor re- sponse to preoperative chemoradiation with or without ox- aliplatin in locally advanced rectal cancer:p~ithologic re- suhs of the STAR-01 randomized phase III trial 显示文摘	Aschele C Cionini L Lonardi S	2011	J Clin Oncol2011，29，20：	1
19	Muhidisciplinary treatment of rectal cancer: medical oncology 显示文摘	Aschele C Lonardi S	2007	Ann Oncol2007，18，11：	1
20	A parallel edge-betweenness clustering tool for protein-protein interaction networks显示文摘	Yang Qiao-feng Lonardi S	2007	Int J Data Mining and Bioinformaties2007，1，3：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示